FMP
CohBar, Inc.
CWBR
NASDAQ
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 analogs for fibrotic diseases; and CB5064 analogs for COVID-19 associated ARDS. CohBar, Inc. was incorporated in 2007 and is headquartered in Menlo Park, California.
0.8 USD
-0.1003 (-12.54%)
About
ceo
Dr. Pinchas Cohen Dean, M.D.
sector
Healthcare
industry
Biotechnology
website
https://www.cohbar.com
exchange
NASDAQ
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute respiratory distress syndrome, cancer, and cardiovascular diseases, such as Alzheimer's disease. Its lead clinical candidate is CB4211, a novel refined analog of the MOTS-c mitochondrial derived peptide, which is in Phase Ib stage of a Phase Ia/Ib clinical trial for the treatment of NASH and obesity. The company's preclinical programs include CB5138 ...
CIK
0001522602
ISIN
US19249J3077
CUSIP
19249J109
Address
1455 Adams Drive
Phone
650 446 7888
Country
US
Employee
9
IPO Date
Dec 15, 2017
Summary
CIK
0001522602
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
19249J109
ISIN
US19249J3077
Country
US
Price
0.8
Beta
1.59
Volume Avg.
2.2k
Market Cap
2.33M
Shares
-
52-Week
0.5103-6.9
DCF
2.04
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.18
P/B
-
Website
https://www.cohbar.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CWBR News
It looks like there's no news available.
